Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
11
×
Tags
fda
life sciences
national blog main
biotech
clinical trials
boston blog main
eli lilly
indiana blog main
indiana top stories
san francisco blog main
san francisco top stories
archive
avapritinib
blueprint medicines
boston
boston top stories
europe blog main
europe top stories
medical
national top stories
amgen
cancer
genentech
medullary thyroid cancer
new york blog main
new york top stories
non-small cell lung cancer
pralsetinib
raleigh-durham blog main
raleigh-durham top stories
roche
selpercatinib
thyroid cancer
abaloparatide
aimmune therapeutics
allergy
alprazolam
anaphylaxis
andrew berens
andrew oxtoby
What
approval
11
×
drug
11
×
fda
administration
food
blueprint
cancer
review
announced
approved
approves
carries
certain
developed
eli
friday
health
heart
lilly
marketing
medicine
medicines
ret
therapy
time
type
vaccine
wins
won
acute
address
addresses
admini
age
agency
aimmune
algorithm
allergy
allow
amgen
Language
unset
11
×
Current search:
drug
×
unset
×
photo
×
approval
×
@engadget.com
2 years ago
Google seeks FDA approval for Fitbit's passive heart rate monitoring tech
@slashgear.com
2 years ago
Pfizer and Moderna near two major milestones as FDA fuels vaccine review
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@slashgear.com
4 years ago
FDA approves first US Ebola vaccine: What you should know
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@slashgear.com
4 years ago
Superbug tuberculosis treatment gets FDA approval as cases skyrocket
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug